Press Room

ECA Conference: Spray Drying - Solutions for Pharmaceutical Industry

Start
Thursday, June 09, 2016 - 00:00
End
Thursday, June 09, 2016 - 00:00
Location: Loures, Portugal

In this three days conference dedicated to Spray Drying solutions, on the last day attendees have the opportunity to take advantage of an exclusive hands-on training. For that purpose several spray dryers are available at Hovione.

Hovione hosts a hands-on spray drying session in its site in Loures

Our experts provide an intensive experience and directly applicable know-how.

 
Hightlights:
  • how scale-up is done through mathematical modelling and how to take advantage
  • of scale-up to significantly improve powder properties.
  • how to develop a process under QbD, how to optimise production parameters and how to proceed
  • a scale-up from laboratory to industrial scale.
  • how to analyse and evaluate your product.
  • pratical exercise: having the chance to spray dry a material both at lab and commercial scale.
For more details about our tecnhologies contact us

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025